KFL undiluted NAV as at 24/8/22 - $1.4880

MKTUPDTE
Thu, Aug 25 2022 01:55 pm

KFL undiluted NAV as at 24/8/22 - $1.4880

Date 24/8/2022 17/8/2022
KFL undiluted NAV $1.4880 $1.5148
Share price close $1.62 $1.70
(Premium) (9%) (12%)

The above net asset value (NAV) is unaudited and net of fees and tax.

The NAV per share is calculated after deducting treasury stock (shares acquired under the Kingfish buyback programme) - currently nil.

* The undiluted NAV excludes any impact on the NAV of the future exercise of warrants (KFLWG). At 24 August 2022, 79,075,168 warrants are on issue and may be exercised on 18 November 2022. The actual exercise price of each warrant is $2.03 less the dividends per share declared by the company with a record date between 15 November 2021 and the announcement of the 18 November 2022 exercise price. Dividends totalling 13.21 cents per share have been declared to date and there are no more dividends expected to be declared in the remaining period up to the announcement of the 18 November 2022 exercise price.

The five largest portfolio holdings at 24 August 2022 are approximately as follows:

Mainfreight 17%
Infratil 17%
Fisher & Paykel Healthcare 14%
Summerset 11%
Auckland International Airport 9%

BACKGROUND
Kingfish is a listed investment company that invests in growing New Zealand companies. The Kingfish portfolio is managed by Fisher Funds, a specialist investment manager with a track record of successfully investing in growth company shares. The aim of Kingfish is to offer investors competitive returns through capital growth and dividends, and access to a diversified portfolio of investments through a single tax-efficient investment vehicle. Kingfish listed on NZX Main Board on 31 March 2004 and may invest in companies that are listed on a New Zealand stock exchange or unlisted companies.

Contact
Corporate Manager
Kingfish Limited
Tel +64 9 4840352


Announcement PDF


Markets News

F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

Finance

‘Unusual’ volume of CCCFA changes in focus

Select committee mulls proposed changes to CCCFA, to report recommendations Oct 20.

‘Unusual’ volume of CCCFA changes in focus
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

Gregor Thompson 15 Sep 2025
NZX 50 dips despite Fletcher Building's 4.6% gain